États-Unis · Plateformes & données · MarketBeat

Nuvation Bio Inc. (NYSE:NUVB) Stock Has Average Target Price of $13.22

Publié par MarketBeat · États-Unis il y a 1 h

Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) has been given an average rating of "Moderate Buy" by the twelve research firms that are covering the stock, MarketBeat.com…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Nuvation Bio Inc. (NYSE:NUVB) Stock Has Average Target Price of $13.22

À lire aussi

Where Will Neurocrine Biosciences Be in 5 Years?

Best Stocks to Day Trade

Explainer-How Ukraine’s strikes on Russian energy sites deepened the rift with Trump

Jamie Dimon warns of 5 big threats to the US economy — how America’s biggest bank is protecting itself now (copy them)

Soaring Oil Prices Could Benefit These 2 ‘Strong Buy’ Energy Stocks

Audi to build $4.2B auto plant in Georgia, pledging long-term investment in U.S. market

Nuvation Bio Inc. (NYSE:NUVB) Stock Has Average Target Price of $13.22

Partager

À lire aussi

Where Will Neurocrine Biosciences Be in 5 Years?

Best Stocks to Day Trade

Explainer-How Ukraine’s strikes on Russian energy sites deepened the rift with Trump

Jamie Dimon warns of 5 big threats to the US economy — how America’s biggest bank is protecting itself now (copy them)

Soaring Oil Prices Could Benefit These 2 ‘Strong Buy’ Energy Stocks

Audi to build $4.2B auto plant in Georgia, pledging long-term investment in U.S. market